BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 22917208)

  • 41. MRI-targeted repetitive transcranial magnetic stimulation of Heschl's gyrus for refractory auditory hallucinations.
    Blumberger DM; Christensen BK; Zipursky RB; Moller B; Chen R; Fitzgerald PB; Daskalakis ZJ
    Brain Stimul; 2012 Oct; 5(4):577-85. PubMed ID: 22410480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study.
    Mogg A; Purvis R; Eranti S; Contell F; Taylor JP; Nicholson T; Brown RG; McLoughlin DM
    Schizophr Res; 2007 Jul; 93(1-3):221-8. PubMed ID: 17478080
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine.
    de Jesus DR; Gil A; Barbosa L; Lobato MI; Magalhães PV; Favalli GP; Marcolin MA; Daskalakis ZJ; Belmonte-de-Abreu Pda S
    Psychiatry Res; 2011 Jul; 188(2):203-7. PubMed ID: 21186062
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maintenance treatment with transcranial magnetic stimulation in a patient with late-onset schizophrenia.
    Poulet E; Brunelin J; Kallel L; D'Amato T; Saoud M
    Am J Psychiatry; 2008 Apr; 165(4):537-8. PubMed ID: 18381921
    [No Abstract]   [Full Text] [Related]  

  • 45. Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.
    Slotema CW; Blom JD; Hoek HW; Sommer IE
    J Clin Psychiatry; 2010 Jul; 71(7):873-84. PubMed ID: 20361902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improvement of auditory hallucinations and reduction of primary auditory area's activation following TMS.
    Giesel FL; Mehndiratta A; Hempel A; Hempel E; Kress KR; Essig M; Schröder J
    Eur J Radiol; 2012 Jun; 81(6):1273-5. PubMed ID: 21459534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exacerbation of auditory verbal hallucinations with adjunctive high-frequency cerebellar vermal repetitive transcranial magnetic stimulation in schizophrenia: a case report.
    Garg S; Goyal N; Tikka SK; Sinha VK
    J ECT; 2013 Mar; 29(1):65-6. PubMed ID: 23303419
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stabilization of the internal structure of persistent auditory verbal hallucinations in schizophrenia.
    Chang JS; Yi JS; Ahn YM; Kim JH; Kim YS
    Aust N Z J Psychiatry; 2009 Mar; 43(3):244-51. PubMed ID: 19221913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dichotic listening in schizophrenic patients: effects of previous vs. ongoing auditory hallucinations.
    Løberg EM; Jørgensen HA; Hugdahl K
    Psychiatry Res; 2004 Sep; 128(2):167-74. PubMed ID: 15488959
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asymmetry of temporal lobe phosphorous metabolism in schizophrenia: a 31phosphorous magnetic resonance spectroscopic imaging study.
    Deicken RF; Calabrese G; Merrin EL; Vinogradov S; Fein G; Weiner MW
    Biol Psychiatry; 1995 Sep; 38(5):279-86. PubMed ID: 7495921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The temporolimbic system theory of positive schizophrenic symptoms.
    Bogerts B
    Schizophr Bull; 1997; 23(3):423-35. PubMed ID: 9327507
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can fMRI-guidance improve the efficacy of rTMS treatment for auditory verbal hallucinations?
    Sommer IE; de Weijer AD; Daalman K; Neggers SF; Somers M; Kahn RS; Slotema CW; Blom JD; Hoek HW; Aleman A
    Schizophr Res; 2007 Jul; 93(1-3):406-8. PubMed ID: 17478084
    [No Abstract]   [Full Text] [Related]  

  • 53. A sham-controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations.
    Loo CK; Sainsbury K; Mitchell P; Hadzi-Pavlovic D; Sachdev PS
    Psychol Med; 2010 Apr; 40(4):541-6. PubMed ID: 19656432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcranial Direct Current Stimulation as Monotherapy Attenuates Auditory Hallucinations in Treatment-Naïve First-Episode Schizophrenia.
    Goyal P; Kataria L; Andrade C
    J ECT; 2016 Sep; 32(3):e15-6. PubMed ID: 27128721
    [No Abstract]   [Full Text] [Related]  

  • 55. Insight facilitation with add-on tDCS in schizophrenia.
    Bose A; Shivakumar V; Narayanaswamy JC; Nawani H; Subramaniam A; Agarwal SM; Chhabra H; Kalmady SV; Venkatasubramanian G
    Schizophr Res; 2014 Jun; 156(1):63-5. PubMed ID: 24767881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of auditory hallucinations with bilateral theta burst stimulation (cTBS): protocol of a randomized, double-blind, placebo-controlled, multicenter trial.
    Plewnia C; Brendel B; Schwippel T; Martus P; Cordes J; Hasan A; Fallgatter AJ
    Eur Arch Psychiatry Clin Neurosci; 2018 Oct; 268(7):663-673. PubMed ID: 29224040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Priming does not enhance the efficacy of 1 Hertz repetitive transcranial magnetic stimulation for the treatment of auditory verbal hallucinations: results of a randomized controlled study.
    Slotema CW; Blom JD; de Weijer AD; Hoek HW; Sommer IE
    Brain Stimul; 2012 Oct; 5(4):554-9. PubMed ID: 22070919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global and temporal cortical folding in patients with early-onset schizophrenia.
    Penttilä J; Paillére-Martinot ML; Martinot JL; Mangin JF; Burke L; Corrigall R; Frangou S; Cachia A
    J Am Acad Child Adolesc Psychiatry; 2008 Oct; 47(10):1125-32. PubMed ID: 18725863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine.
    Rosa MO; Gattaz WF; Rosa MA; Rumi DO; Tavares H; Myczkowski M; Sartorelli MC; Rigonatti SP; Elkis H; Cabral SB; Teixeira MJ; Marcolin MA
    J Clin Psychiatry; 2007 Oct; 68(10):1528-32. PubMed ID: 17960967
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study.
    Levkovitz Y; Rabany L; Harel EV; Zangen A
    Int J Neuropsychopharmacol; 2011 Aug; 14(7):991-6. PubMed ID: 21524336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.